| |
| |
Gene Symbol |
ADRB2 |
| |
Aliases |
ADRB2R, ADRBR, B2AR, BAR, BETA2AR |
| |
Entrez Gene ID |
|
| |
Gene Name |
Adrenoceptor beta 2 |
| |
Chromosomal Location |
5q32 |
| |
HGNC ID |
|
| |
Summary |
This gene encodes beta-2-adrenergic receptor which is a member of the G protein-coupled receptor superfamily. This receptor is directly associated with one of its ultimate effectors, the class C L-type calcium channel Ca(V)1.2. This receptor-channel complex also contains a G protein, an adenylyl cyclase, cAMP-dependent kinase, and the counterbalancing phosphatase, PP2A. The assembly of the signaling complex provides a mechanism that ensures specific and rapid signaling by this G protein-coupled receptor. This receptor is also a transcription regulator of the alpha-synuclein gene, and together, both genes are believed to be associated with risk of Parkinson's Disease. This gene is intronless. Different polymorphic forms, point mutations, and/or downregulation of this gene are associated with nocturnal asthma, obesity, type 2 diabetes and cardiovascular disease. [provided by RefSeq, Oct 2019]
|
| |
RefSeq DNA |
|
| |
RefSeq mRNA |
|
| |
e!Ensembl
|
|
Gene Ontology (GO)
| GO ID |
Ontology |
Function |
Evidence |
Reference |
| GO:0002025 |
Biological process |
Norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure |
IBA |
21873635 |
| GO:0002032 |
Biological process |
Desensitization of G protein-coupled receptor signaling pathway by arrestin |
IDA |
15123695 |
| GO:0006898 |
Biological process |
Receptor-mediated endocytosis |
IDA |
15123695 |
| GO:0007166 |
Biological process |
Cell surface receptor signaling pathway |
TAS |
1371121 |
| GO:0007171 |
Biological process |
Activation of transmembrane receptor protein tyrosine kinase activity |
TAS |
10734107 |
| GO:0007188 |
Biological process |
Adenylate cyclase-modulating G protein-coupled receptor signaling pathway |
IBA |
21873635 |
| GO:0007190 |
Biological process |
Activation of adenylate cyclase activity |
IDA |
15123695 |
| GO:0008333 |
Biological process |
Endosome to lysosome transport |
TAS |
9507004 |
| GO:0010739 |
Biological process |
Positive regulation of protein kinase A signaling |
IGI |
20395454 |
| GO:0031398 |
Biological process |
Positive regulation of protein ubiquitination |
IMP |
19372219 |
| GO:0043410 |
Biological process |
Positive regulation of MAPK cascade |
IDA |
15123695 |
| GO:0045986 |
Biological process |
Negative regulation of smooth muscle contraction |
IBA |
21873635 |
| GO:0071875 |
Biological process |
Adrenergic receptor signaling pathway |
IDA |
19710023 |
| GO:0071880 |
Biological process |
Adenylate cyclase-activating adrenergic receptor signaling pathway |
IBA |
21873635 |
| GO:0071902 |
Biological process |
Positive regulation of protein serine/threonine kinase activity |
IGI |
20395454 |
| GO:0120162 |
Biological process |
Positive regulation of cold-induced thermogenesis |
ISS |
12387862 |
| GO:1901098 |
Biological process |
Positive regulation of autophagosome maturation |
IDA |
23708524 |
| GO:1904504 |
Biological process |
Positive regulation of lipophagy |
IDA |
23708524 |
| GO:1904646 |
Biological process |
Cellular response to amyloid-beta |
IGI |
20395454 |
| GO:1990911 |
Biological process |
Response to psychosocial stress |
TAS |
20395454 |
| GO:2000481 |
Biological process |
Positive regulation of cAMP-dependent protein kinase activity |
TAS |
20395454 |
| GO:2000969 |
Biological process |
Positive regulation of AMPA receptor activity |
IGI |
20395454 |
| GO:0005764 |
Cellular component |
Lysosome |
TAS |
9507004 |
| GO:0005768 |
Cellular component |
Endosome |
TAS |
10734107 |
| GO:0005886 |
Cellular component |
Plasma membrane |
IDA |
9235896 |
| GO:0005887 |
Cellular component |
Integral component of plasma membrane |
IBA |
21873635 |
| GO:0005887 |
Cellular component |
Integral component of plasma membrane |
IDA |
12297500, 19710023 |
| GO:0016020 |
Cellular component |
Membrane |
NAS |
20395454 |
| GO:0043235 |
Cellular component |
Receptor complex |
IDA |
15123695, 23382219 |
| GO:0001540 |
Molecular function |
Amyloid-beta binding |
IDA |
20395454 |
| GO:0004935 |
Molecular function |
Adrenergic receptor activity |
IBA |
21873635 |
| GO:0004941 |
Molecular function |
Beta2-adrenergic receptor activity |
IBA |
21873635 |
| GO:0004941 |
Molecular function |
Beta2-adrenergic receptor activity |
IDA |
15123695, 19710023 |
| GO:0004941 |
Molecular function |
Beta2-adrenergic receptor activity |
NAS |
20395454 |
| GO:0005515 |
Molecular function |
Protein binding |
IPI |
9560162, 9671706, 15123695, 17148612, 17170700, 19424180, 19584355, 20353789, 20733053, 23208550, 23236378, 24405750, 28298427 |
| GO:0015459 |
Molecular function |
Potassium channel regulator activity |
IDA |
12297500 |
| GO:0042803 |
Molecular function |
Protein homodimerization activity |
IDA |
15123695 |
| GO:0044877 |
Molecular function |
Protein-containing complex binding |
IPI |
20395454 |
| GO:0051379 |
Molecular function |
Epinephrine binding |
IBA |
21873635 |
| GO:0051380 |
Molecular function |
Norepinephrine binding |
IDA |
15123695 |
|
| Protein Information |
| |
Protein Name |
Beta-2 adrenergic receptor, adrenergic, beta-2-, receptor, surface, adrenoceptor beta 2 surface, beta-2 adrenoceptor, beta-2 adrenoreceptor, catecholamine receptor |
| |
Function |
|
Beta-adrenergic receptors mediate the catecholamine-induced activation of adenylate cyclase through the action of G proteins. The beta-2-adrenergic receptor binds epinephrine with an approximately 30-fold greater affinity than it does norepinephrine. |
|
| |
|
|
| |
UniProt |
|
| |
PDB |
1GQ4, 2R4R, 2R4S, 2RH1, 3D4S, 3KJ6, 3NY8, 3NY9, 3NYA, 3P0G, 3PDS, 3SN6, 4GBR, 4LDE, 4LDL, 4LDO, 4QKX, 5D5A, 5D5B, 5D6L, 5JQH, 5X7D, 6MXT |
|
|
|
|
Interactions |
| | |
| STRING |
MINT |
IntAct |
| ENSP00000307298 |
Q9UK73 |
Q9UK73 |
|
| | |
View interactions
|
| |
| |
Associated Diseases
| Disease group | Disease Name | References |
| Cardiovascular Diseases |
| Myocardial Ischemia |
|
| Myocardial Diseases |
|
| Cardiomyopathy |
|
| Endocrine System Diseases |
| PCOS |
|
| Immune System Diseases |
| HIV Encephalopathy |
|
| AIDS Dementia Complex |
|
| HIV Infections |
|
| HIV Coinfection |
|
| Neoplasms |
| Stomach Cancer |
|
| Prostate cancer |
|
| Gastric Cancer |
|
| Nervous System Diseases |
| Viral Encephalitis |
|
| Nutritional and Metabolic Diseases |
| Obesity |
|
| Hyperlipidemia |
|
| Psychiatric/Brain disorders |
| Autistic Disorder |
|
| Bipolar Disorder |
|
| Obstructive Sleep Apnea |
|
| Reproductive disorders |
| Preeclampsia |
|
|
|
References |
| |
|
| |
| PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
BAR-3 |
Insulin resistance |
Polymorphism in codon 27 (Gln27Glu) of BAR-2 |
|
Direct
|
Japanese-59 infertile PCOS & 97 healthy controls |
The polymorphism in codon 27 (Gln27Glu) of BAR-2 is linked to the expression of PCOS in Japanese women |
|
|
|